Achieve Life Sciences (ACHV) Assets Average (2011 - 2026)

Achieve Life Sciences (ACHV) has 16 years of Assets Average data on file, last reported at $37.4 million in Q1 2026.

• Quarterly Assets Average rose 13.49% year-over-year to $37.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $37.4 million (up 13.49% YoY) and the FY2025 annual result came in at $40.2 million, up 38.65% from the prior year.
• Assets Average declined to $37.4 million in Q1 2026, from $46.9 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $67.4 million in Q2 2024 to a low of $21.9 million in Q4 2023.
• A 5-year average of $39.0 million and a median of $37.4 million in 2026 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2023 — Assets Average sank 42.39% — and 2024, when it soared 171.2%.
• Tracing ACHV's Assets Average over 5 years: stood at $26.8 million in 2022, then dropped by 18.6% to $21.9 million in 2023, then soared by 98.02% to $43.3 million in 2024, then grew by 8.41% to $46.9 million in 2025, then slipped by 20.18% to $37.4 million in 2026.
• The last three Assets Average figures came in at $37.4 million (Q1 2026), $46.9 million (Q4 2025), and $55.5 million (Q3 2025), per Business Quant data.